الأدلة
[1] المنشور الأصلي
Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. FIB-4 = (age·AST)/(platelets·√ALT); < 1.45 had a 90% negative predictive value for advanced fibrosis and > 3.25 a 65% positive predictive value, avoiding biopsy in ~70% of patients.
Hepatology, 2006
[2] التحقق
McPherson S, Hardy T, Dufour JF, et al. Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis. In 634 patients, FIB-4 specificity fell to 35% at age ≥ 65; a lower cut-off of 2.0 was derived and validated for that age group (specificity 70%, sensitivity 77%).
American Journal of Gastroenterology, 2017
[3] الإرشادات
Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Recommends FIB-4 as the primary tool to assess the risk of advanced fibrosis.
Hepatology, 2023
آخر مراجعة: 2026-10
الإبلاغ عن خطأ في هذه الحاسبة